Trellus Health plc
TRLS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £1,442 | £1,061 | £3,473 | £6,682 |
| - Cash | £1,568 | £4,344 | £8,045 | £12,166 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£126 | -£3,283 | -£4,572 | -£5,484 |
| Revenue | £295 | £64 | £50 | £5 |
| % Growth | 360.9% | 28% | 900% | – |
| Gross Profit | £295 | £64 | £50 | £5 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -£2,987 | -£3,942 | -£4,021 | -£3,022 |
| % Margin | -1,012.5% | -6,159.4% | -8,042% | -60,440% |
| Net Income | -£2,997 | -£3,891 | -£3,891 | -£2,772 |
| % Margin | -1,015.9% | -6,079.7% | -7,782% | -55,440% |
| EPS Diluted | -0.019 | -0.024 | -0.024 | -0.017 |
| % Growth | 22.8% | 0% | -40.1% | – |
| Operating Cash Flow | -£2,534 | -£3,624 | -£3,697 | -£2,159 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£2,534 | -£3,624 | -£3,697 | -£2,159 |